FDA Raises Concerns Over Unapproved GLP-1 Drugs Including Retatrutide | Retatrutide News

The FDA has raised concerns about the use of unapproved GLP-1 agonists like Retatrutide for weight loss. This highlights the need for thorough regulator...
Market News · October 23, 2026